Displaying items by tag: department of neurology

UAB neurologists have reported the first case study of a patient with a brain bleed linked to consumption of an energy drink.
The power and promise of personalized medicine: a genetic test can reduce cardiovascular risk for some heart patients
A UAB study will test whether training to modify care-resistant behavior can improve quality of life for family caregivers of dementia patients.
UAB and Auburn will team up for a study of magnetic resonance imaging techniques that could enhance epilepsy surgery.
UAB investigators have won a prestigious White House BRAIN Initiative grant to study the potential benefits of new technology coupled with newly discovered biomarkers in deep brain stimulation for Parkinson’s disease.

UAB and partners launch the PREVeNT study, aimed at preventing the onset of seizures in children with tuberous sclerosis.

best of 2016After major investments in information technology infrastructure — bringing the fastest supercomputer in Alabama to campus — UAB can now execute tasks in a couple of hours that took an entire day just a year ago. 

For a second summer, Maria Onatunde traveled to UAB from Florida to participate in UAB's PARAdiGM program, which offers in-depth research experience for undergraduates from disadvantaged and minority backgrounds.

A UAB study sheds light on and suggests a target for treatment of a variant of Guillain-Barré syndrome.

An intriguing paper by Harvard researchers has everyone talking, thanks to widespread media coverage. Neuroscientist Erik Roberson, M.D., Ph.D., co-director of UAB's Center for Neurodegeneration and Experimental Therapeutics, offers his thoughts on a discovery gone viral.
Results show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.
UAB joins with leading Parkinson’s disease organizations for a Birmingham conference.
Preliminary results from UAB’s CBD oil studies show benefit in seizure control in some patients.
A key role for microRNA-155 in brain inflammation and neurodegeneration makes it both a potential therapeutic target and a biomarker for this progressive disorder.
Alabama ALS chapter honors UAB’s Peter King with Spirit of Lou Gehrig Award.
Page 7 of 12